Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103254 · ClinicalTrials.gov registry record
Bempedoic Acid Pregnancy Surveillance Program
A clinical trial of Pregnancy and Hyperlipidemias, sponsored by Esperion Therapeutics.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05103254: Recruiting study of Pregnancy and Hyperlipidemias, sponsored by Esperion Therapeutics.
NCT05103254 is a study of Pregnancy and Hyperlipidemias that is actively recruiting participants, run by Esperion Therapeutics. The registered enrollment target is 20 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05103254, a study of Pregnancy and Hyperlipidemias, is actively recruiting participants, sponsored by Esperion Therapeutics.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Bempedoic acid pregnancy surveillance program
Primary Outcome
An abnormality of body structure or function that is present at birth, is of prenatal origin (i.e., birth defect), has significant medical, social, or cosmetic consequences for the affected individual, and typically requires medical intervention (CDC 2019a). MCMs will be defined and coded with criteria specified by US CDC Metropolitan Atlanta Congenital Defects Program (MACDP).
Conditions Studied
Interventions
- DRUG Bempedoic Acid
- DRUG Bempedoic Acid / Ezetimibe
Study Locations (1)
North Carolina
- Evidera, PPD business unit - Morrisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2032-05 |
What NCT05103254 shows while recruiting
NCT05103254 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Bempedoic Acid is the first listed.
NCT05103254 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05103254 about?
NCT05103254 is a clinical study titled "Bempedoic Acid Pregnancy Surveillance Program". Bempedoic acid pregnancy surveillance program
What is the current status of trial NCT05103254?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2021-09-01. Estimated completion is 2032-05.
What conditions does trial NCT05103254 study?
This clinical trial studies the following conditions: Pregnancy, Hyperlipidemias.
What interventions are being tested in trial NCT05103254?
The interventions under investigation include: Bempedoic Acid (DRUG), Bempedoic Acid / Ezetimibe (DRUG).
Who is sponsoring clinical trial NCT05103254?
This trial is sponsored by Esperion Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05103254 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05103254's enrollment target sits among peer trials
20 181st of 191 higher than 10 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI